HIGH-FIELD H-1 AND P-31 NMR-STUDIES ON THE BINDING OF THE ANTICANCER AGENT MITOXANTRONE TO D[CPGPAPTPCPG]2

被引：37

作者：

KOTOVYCH, G

LOWN, JW

TONG, JPK

机构：

来源：

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS | 1986年 / 4卷 / 01期

关键词：

D O I：

10.1080/07391102.1986.10507649

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：111 / 125

页数：15

共 31 条

[1] PHASE-I CLINICAL-TRIAL OF MITOXANTRONE - A NEW ANTHRACENEDIONE ANTI-CANCER DRUG [J].

ALBERTS, DS ;

GRIFFITH, KS ;

GOODMAN, GE ;

HERMAN, TS ;

MURRAY, E .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) :11-15

[2]

BAX A, 1982, 2 DIMENSIONAL NUCLEA, P59

[3]

BOWDEN GT, 1982, CANCER RES, V42, P2660

[4]

CHANDRASEKARAN S, 1985, BIOPOLYMERS, V24, P1963, DOI 10.1002/bip.360241009

[5] NMR-STUDIES ON OLIGODEOXYRIBONUCLEOTIDES CONTAINING THE DAM METHYLATION SITE GATC - COMPARISON BETWEEN D(GGATCC) AND D(GGM6ATCC) [J].

FAZAKERLEY, GV ;

TEOULE, R ;

GUY, A ;

FRITZSCHE, H ;

GUSCHLBAUER, W .

BIOCHEMISTRY, 1985, 24 (17) :4540-4548

[6] DNA-BINDING SPECIFICITY AND RNA-POLYMERASE INHIBITORY ACTIVITY OF BIS(AMINOALKYL)ANTHRAQUINONES AND BIS(METHYLTHIO)VINYLQUINOLINIUM IODIDES [J].

FOYE, WO ;

VAJRAGUPTA, O ;

SENGUPTA, SK .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (02) :253-257

[7]

FREDERICK CA, 1985, 4TH CONV BIOM STER, P171

[8]

Gale EF, 1981, MOL BASIS ANTIBIOTIC

[9]

GIESSNERPRETTRE C, 1976, CR ACAD SCI D NAT, V283, P675

[10]

Gorenstein D. G., 1984, PHOSPHOROUS 31 NMR P, P37

← 1 2 3 4 →